Variant Summary
- Also known as
- RS121913530,GLY12SER
- HGVS
- NM_004985.4:c.34G>A,NP_004976.2:p.Gly12Ser,NC_000012.11:g.25398285C>T,ENST00000256078.4:c.34G>A
- Variant Type(s)
- missense_variant
- Evidence Items
- 8
Evidence Level Distribution
Level B: 2Level C: 2Level D: 4
Evidence Items
Showing CIViC evidence rows where gene = KRAS and variant = G12S.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| B | Predictive | Supports | Resistance | Colorectal Cancer | Cetuximab | 3 |
| B | Predictive | Supports | Resistance | Lung Cancer | Gefitinib | 2 |
| D | Predictive | Supports | Resistance | Multiple Myeloma | Melphalan | 2 |
| D | Predictive | Supports | Resistance | Multiple Myeloma | Melphalan | 2 |
| D | Predictive | Supports | Resistance | Multiple Myeloma | Melphalan | 2 |
| D | Predictive | Supports | Resistance | Colorectal Cancer | Regorafenib Anhydrous | 2 |
| C | Predictive | Supports | Resistance | Colorectal Cancer | Panitumumab,Cetuximab | 2 |
| C | Predictive | Supports | Resistance | Colorectal Cancer | Panitumumab | 0 |